Clinical Trial Update: Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating recombinant human thrombopoietin (rhTPO) for chemotherapy-induced thrombocytopenia in patients with acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Antineoplastic Adverse Reaction, Thrombocytopenia | Phase 3 | Status: UNKNOWN